Global Heparin Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Heparin Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. This report is revolving around Heparin Active Pharmaceutical Ingredients (API).

According to APO Research, The global Heparin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Heparin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Heparin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Heparin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Heparin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Heparin include Hepalink, Changshan Pharm, Qianhong Bio-pharma, Opocrin, Pfizer, Aspen Oss, King-friend Biochemical Pharmaceutical, Bioibérica and Dongcheng Biochemicals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Heparin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Heparin, also provides the sales of main regions and countries. Of the upcoming market potential for Heparin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Heparin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Heparin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Heparin sales, projected growth trends, production technology, application and end-user industry.

Heparin segment by Company

Hepalink
Changshan Pharm
Qianhong Bio-pharma
Opocrin
Pfizer
Aspen Oss
King-friend Biochemical Pharmaceutical
Bioibérica
Dongcheng Biochemicals
Jiulong Biochemicals
Tiandong
Xinbai
Yino Pharma
Deebio
Heparin segment by Type

Heparin Sodium Raw Material Drug
Heparin Calcium Raw Material Drug
Heparin segment by Application

Low Molecular Weight Heparin Preparation
Standard Heparin Preparation
Heparin segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Heparin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Heparin market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Heparin significant trends, drivers, influence factors in global and regions.
6. To analyze Heparin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heparin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Heparin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heparin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Heparin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Heparin industry.
Chapter 3: Detailed analysis of Heparin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Heparin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Heparin in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Heparin Sales Value (2019-2030)
1.2.2 Global Heparin Sales Volume (2019-2030)
1.2.3 Global Heparin Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Heparin Market Dynamics
2.1 Heparin Industry Trends
2.2 Heparin Industry Drivers
2.3 Heparin Industry Opportunities and Challenges
2.4 Heparin Industry Restraints
3 Heparin Market by Company
3.1 Global Heparin Company Revenue Ranking in 2023
3.2 Global Heparin Revenue by Company (2019-2024)
3.3 Global Heparin Sales Volume by Company (2019-2024)
3.4 Global Heparin Average Price by Company (2019-2024)
3.5 Global Heparin Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Heparin Company Manufacturing Base & Headquarters
3.7 Global Heparin Company, Product Type & Application
3.8 Global Heparin Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Heparin Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Heparin Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 Heparin Market by Type
4.1 Heparin Type Introduction
4.1.1 Heparin Sodium Raw Material Drug
4.1.2 Heparin Calcium Raw Material Drug
4.2 Global Heparin Sales Volume by Type
4.2.1 Global Heparin Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Heparin Sales Volume by Type (2019-2030)
4.2.3 Global Heparin Sales Volume Share by Type (2019-2030)
4.3 Global Heparin Sales Value by Type
4.3.1 Global Heparin Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Heparin Sales Value by Type (2019-2030)
4.3.3 Global Heparin Sales Value Share by Type (2019-2030)
5 Heparin Market by Application
5.1 Heparin Application Introduction
5.1.1 Low Molecular Weight Heparin Preparation
5.1.2 Standard Heparin Preparation
5.2 Global Heparin Sales Volume by Application
5.2.1 Global Heparin Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Heparin Sales Volume by Application (2019-2030)
5.2.3 Global Heparin Sales Volume Share by Application (2019-2030)
5.3 Global Heparin Sales Value by Application
5.3.1 Global Heparin Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Heparin Sales Value by Application (2019-2030)
5.3.3 Global Heparin Sales Value Share by Application (2019-2030)
6 Heparin Market by Region
6.1 Global Heparin Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Heparin Sales by Region (2019-2030)
6.2.1 Global Heparin Sales by Region: 2019-2024
6.2.2 Global Heparin Sales by Region (2025-2030)
6.3 Global Heparin Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Heparin Sales Value by Region (2019-2030)
6.4.1 Global Heparin Sales Value by Region: 2019-2024
6.4.2 Global Heparin Sales Value by Region (2025-2030)
6.5 Global Heparin Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Heparin Sales Value (2019-2030)
6.6.2 North America Heparin Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Heparin Sales Value (2019-2030)
6.7.2 Europe Heparin Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Heparin Sales Value (2019-2030)
6.8.2 Asia-Pacific Heparin Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Heparin Sales Value (2019-2030)
6.9.2 Latin America Heparin Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Heparin Sales Value (2019-2030)
6.10.2 Middle East & Africa Heparin Sales Value Share by Country, 2023 VS 2030
7 Heparin Market by Country
7.1 Global Heparin Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Heparin Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Heparin Sales by Country (2019-2030)
7.3.1 Global Heparin Sales by Country (2019-2024)
7.3.2 Global Heparin Sales by Country (2025-2030)
7.4 Global Heparin Sales Value by Country (2019-2030)
7.4.1 Global Heparin Sales Value by Country (2019-2024)
7.4.2 Global Heparin Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Heparin Sales Value Growth Rate (2019-2030)
7.5.2 Global Heparin Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Heparin Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Heparin Sales Value Growth Rate (2019-2030)
7.6.2 Global Heparin Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Heparin Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Heparin Sales Value Growth Rate (2019-2030)
7.7.2 Global Heparin Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Heparin Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Heparin Sales Value Growth Rate (2019-2030)
7.8.2 Global Heparin Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Heparin Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Heparin Sales Value Growth Rate (2019-2030)
7.9.2 Global Heparin Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Heparin Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Heparin Sales Value Growth Rate (2019-2030)
7.10.2 Global Heparin Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Heparin Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Heparin Sales Value Growth Rate (2019-2030)
7.11.2 Global Heparin Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Heparin Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Heparin Sales Value Growth Rate (2019-2030)
7.12.2 Global Heparin Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Heparin Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Heparin Sales Value Growth Rate (2019-2030)
7.13.2 Global Heparin Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Heparin Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Heparin Sales Value Growth Rate (2019-2030)
7.14.2 Global Heparin Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Heparin Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Heparin Sales Value Growth Rate (2019-2030)
7.15.2 Global Heparin Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Heparin Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Heparin Sales Value Growth Rate (2019-2030)
7.16.2 Global Heparin Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Heparin Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Heparin Sales Value Growth Rate (2019-2030)
7.17.2 Global Heparin Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Heparin Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Heparin Sales Value Growth Rate (2019-2030)
7.18.2 Global Heparin Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Heparin Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Heparin Sales Value Growth Rate (2019-2030)
7.19.2 Global Heparin Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Heparin Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Heparin Sales Value Growth Rate (2019-2030)
7.20.2 Global Heparin Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Heparin Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Heparin Sales Value Growth Rate (2019-2030)
7.21.2 Global Heparin Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Heparin Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Heparin Sales Value Growth Rate (2019-2030)
7.22.2 Global Heparin Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Heparin Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Heparin Sales Value Growth Rate (2019-2030)
7.23.2 Global Heparin Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Heparin Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 Hepalink
8.1.1 Hepalink Comapny Information
8.1.2 Hepalink Business Overview
8.1.3 Hepalink Heparin Sales, Value and Gross Margin (2019-2024)
8.1.4 Hepalink Heparin Product Portfolio
8.1.5 Hepalink Recent Developments
8.2 Changshan Pharm
8.2.1 Changshan Pharm Comapny Information
8.2.2 Changshan Pharm Business Overview
8.2.3 Changshan Pharm Heparin Sales, Value and Gross Margin (2019-2024)
8.2.4 Changshan Pharm Heparin Product Portfolio
8.2.5 Changshan Pharm Recent Developments
8.3 Qianhong Bio-pharma
8.3.1 Qianhong Bio-pharma Comapny Information
8.3.2 Qianhong Bio-pharma Business Overview
8.3.3 Qianhong Bio-pharma Heparin Sales, Value and Gross Margin (2019-2024)
8.3.4 Qianhong Bio-pharma Heparin Product Portfolio
8.3.5 Qianhong Bio-pharma Recent Developments
8.4 Opocrin
8.4.1 Opocrin Comapny Information
8.4.2 Opocrin Business Overview
8.4.3 Opocrin Heparin Sales, Value and Gross Margin (2019-2024)
8.4.4 Opocrin Heparin Product Portfolio
8.4.5 Opocrin Recent Developments
8.5 Pfizer
8.5.1 Pfizer Comapny Information
8.5.2 Pfizer Business Overview
8.5.3 Pfizer Heparin Sales, Value and Gross Margin (2019-2024)
8.5.4 Pfizer Heparin Product Portfolio
8.5.5 Pfizer Recent Developments
8.6 Aspen Oss
8.6.1 Aspen Oss Comapny Information
8.6.2 Aspen Oss Business Overview
8.6.3 Aspen Oss Heparin Sales, Value and Gross Margin (2019-2024)
8.6.4 Aspen Oss Heparin Product Portfolio
8.6.5 Aspen Oss Recent Developments
8.7 King-friend Biochemical Pharmaceutical
8.7.1 King-friend Biochemical Pharmaceutical Comapny Information
8.7.2 King-friend Biochemical Pharmaceutical Business Overview
8.7.3 King-friend Biochemical Pharmaceutical Heparin Sales, Value and Gross Margin (2019-2024)
8.7.4 King-friend Biochemical Pharmaceutical Heparin Product Portfolio
8.7.5 King-friend Biochemical Pharmaceutical Recent Developments
8.8 Bioibérica
8.8.1 Bioibérica Comapny Information
8.8.2 Bioibérica Business Overview
8.8.3 Bioibérica Heparin Sales, Value and Gross Margin (2019-2024)
8.8.4 Bioibérica Heparin Product Portfolio
8.8.5 Bioibérica Recent Developments
8.9 Dongcheng Biochemicals
8.9.1 Dongcheng Biochemicals Comapny Information
8.9.2 Dongcheng Biochemicals Business Overview
8.9.3 Dongcheng Biochemicals Heparin Sales, Value and Gross Margin (2019-2024)
8.9.4 Dongcheng Biochemicals Heparin Product Portfolio
8.9.5 Dongcheng Biochemicals Recent Developments
8.10 Jiulong Biochemicals
8.10.1 Jiulong Biochemicals Comapny Information
8.10.2 Jiulong Biochemicals Business Overview
8.10.3 Jiulong Biochemicals Heparin Sales, Value and Gross Margin (2019-2024)
8.10.4 Jiulong Biochemicals Heparin Product Portfolio
8.10.5 Jiulong Biochemicals Recent Developments
8.11 Tiandong
8.11.1 Tiandong Comapny Information
8.11.2 Tiandong Business Overview
8.11.3 Tiandong Heparin Sales, Value and Gross Margin (2019-2024)
8.11.4 Tiandong Heparin Product Portfolio
8.11.5 Tiandong Recent Developments
8.12 Xinbai
8.12.1 Xinbai Comapny Information
8.12.2 Xinbai Business Overview
8.12.3 Xinbai Heparin Sales, Value and Gross Margin (2019-2024)
8.12.4 Xinbai Heparin Product Portfolio
8.12.5 Xinbai Recent Developments
8.13 Yino Pharma
8.13.1 Yino Pharma Comapny Information
8.13.2 Yino Pharma Business Overview
8.13.3 Yino Pharma Heparin Sales, Value and Gross Margin (2019-2024)
8.13.4 Yino Pharma Heparin Product Portfolio
8.13.5 Yino Pharma Recent Developments
8.14 Deebio
8.14.1 Deebio Comapny Information
8.14.2 Deebio Business Overview
8.14.3 Deebio Heparin Sales, Value and Gross Margin (2019-2024)
8.14.4 Deebio Heparin Product Portfolio
8.14.5 Deebio Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Heparin Value Chain Analysis
9.1.1 Heparin Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Heparin Sales Mode & Process
9.2 Heparin Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Heparin Distributors
9.2.3 Heparin Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings